MicroVue™ C5a EIA A021 from QuidelOrtho

Product Specs
ItemMicroVue™ C5a EIA
CompanyQuidelOrtho
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberA021
StorageStore the unopened kit at 2°C to 8°C. Refer to Product Insert for additional storage details
Regulatory StatusFor Research Use Only in the United States. Not for use in diagnostic procedures
Format96 well plate with 12 eight-well strips in a resealable foil pouch
Quantity96 wells/test
ApplicationsELISA
Sample TypeSerum 10 µL, EDTA or Citrated Plasma 20 µL
Assay Time2.5 hours

9975 Summers Ridge Road

San Diego 92121

United States

Phone: (+1) 858 552 1100

(1) Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severityCrit CareFebruary 16, 2023de Nooijer AH, Kotsaki A, Kranidioti E, Kox M, Pickkers P, Toonen EJM, Giamarellos-Bourboulis EJ, Netea MG.

(4) High plasma C5a and C5b-9 levels during quiescent phases are associated to severe antiphospholipid syndrome subsetsClinical and experimental rheumatologyNovember 1, 2022Ruffatti A, Tonello M, Calligaro A, Del Ross T, Favaro M, Zen M, Carletto A, Lotti V, Bertoldo E, Tedesco F, et al.

(6) Comparison of Complement Pathway Activation in Autoimmune GlomerulonephritisKidney international reportsMay 1, 2022Genest DS, Bonnefoy A, Khalili M, Merlen C, Genest G, Lapeyraque AL, Patey N, Smail N, Royal V, Troyanov S.

(7) Complement Activation in Patients With Heat-Related Illnesses: Soluble CD59 Is a Novel Biomarker Indicating Severity of Heat-Related IllnessesCritical care explorationsApril 1, 2022Nakamura Y, Sueyoshi K, Miyoshi Y, Ishihara T, Hirano Y, Kondo Y, Kuroda Y, Iwabuchi K, Okamoto K, Tanaka H.

(8) Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortalityMedical microbiology and immunologyFebruary 1, 2022Leatherdale A, Stukas S, Lei V, West HE, Campbell CJ, Hoiland RL, Cooper J, Wellington CL, Sekhon MS, Pryzdial ELG, et al.

(9) C5a and C5aR1 are key drivers of microvascular platelet aggregation in clinical entities spanning from aHUS to COVID-19Blood advancesJanuary 8, 2022Aiello S, Gastoldi S, Galbusera M, Ruggenenti P, Portalupi V, Rota S, Rubis N, Liguori L, Conti S, Tironi M, et al.

(11) Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity stateJournal of medical virologySeptember 1, 2021Henry BM, Szergyuk I, de Oliveira MHS, Lippi G, Benoit JL, Vikse J, Benoit SW.

(13) von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort studyClinical immunology (Orlando, Fla.)August 1, 2021Chen YY, Han SS, Cao Y, Yu XJ, Zhu L, Luo JC, Song WC, Yu F, Mao YH, Zhao MH.

(14) The Influence of an Elastase-Sensitive Complement C5 Variant on Lupus Nephritis and Its FlareKidney international reportsAugust 1, 2021Toy CR, Song H, Nagaraja HN, Scott J, Greco J, Zhang X, Yu CY, Tumlin JA, Rovin BH, Hebert LA, et al.

(15) Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritisClinical rheumatologyJune 1, 2021Mejia-Vilet JM, Gómez-Ruiz IA, Cruz C, Méndez-Pérez RA, Comunidad-Bonilla RA, Uribe-Uribe NO, Nuñez-Alvarez CA, Morales-Buenrostro LE.

(16) Human Neutrophils Respond to Complement Activation and Inhibition in Microfluidic DevicesFrontiers in immunologyJanuary 1, 2021Muldur S, Vadysirisack DD, Ragunathan S, Tang Y, Ricardo A, Sayegh CE, Irimia D.

(17) Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic MicroangiopathyFrontiers in immunologyJanuary 1, 2021Okamura H, Nakamae H, Shindo T, Ohtani K, Hidaka Y, Ohtsuka Y, Makuuchi Y, Kuno M, Takakuwa T, Harada N, et al.

(18) Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19Frontiers in immunologyJanuary 1, 2021Peerschke EI, Valentino A, So RJ, Shulman S, Ravinder.

(19) Complement activation and endothelial perturbation parallel COVID-19 severity and activityJournal of autoimmunityJanuary 1, 2021Cugno M, Meroni PL, Gualtierotti R, Griffini S, Grovetti E, Torri A, Lonati P, Grossi C, Borghi MO, Novembrino C, et al.

(20) Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progressionClinical kidney journalOctober 1, 2020Prendecki M, Clarke C, Medjeral-Thomas N, McAdoo SP, Sandhu E, Peters JE, Thomas DC, Willicombe M, Botto M, Pickering MC.

Bench Tips for Optimizing ELISA: It All Comes Out in the Wash
August 22, 2013
This article will provide you with tips on washing your ELISA plates using an automated plate washer, with the goal of avoiding high background and high variation (between plates and between replicate wells). read more

MicroVue™ C5a EIA from QuidelOrtho